Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1989 1
1990 2
1991 2
1992 4
1993 2
1994 2
1995 4
1996 2
1997 5
1998 3
1999 5
2000 1
2001 2
2003 4
2004 5
2005 3
2006 7
2007 2
2008 1
2009 5
2010 10
2011 8
2012 15
2013 6
2014 7
2015 7
2016 2
2017 1
2019 4
2020 6
2021 7
2022 9
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice.
Suárez-García I, Alejos B, Hernando V, Viñuela L, Vera García M, Rial-Crestelo D, Pérez Elías MJ, Albendín Iglesias H, Peraire J, Tiraboschi J, Díaz A, Moreno S, Jarrín I; Cohort of the Spanish HIV/AIDS Research Network (CoRIS). Suárez-García I, et al. J Antimicrob Chemother. 2023 Jun 1;78(6):1423-1432. doi: 10.1093/jac/dkad102. J Antimicrob Chemother. 2023. PMID: 37099559 Free PMC article.
Risk factors for developing ventilator-associated lower respiratory tract infection in patients with severe COVID-19: a multinational, multicentre study, prospective, observational study.
Reyes LF, Rodriguez A, Fuentes YV, Duque S, García-Gallo E, Bastidas A, Serrano-Mayorga CC, Ibáñez-Prada ED, Moreno G, Ramirez-Valbuena PC, Ospina-Tascon G, Hernandez G, Silva E, Díaz AM, Jibaja M, Vera-Alarcon M, Díaz E, Bodí M, Solé-Violán J, Ferrer R, Albaya-Moreno A, Socias L, Figueroa W, Lozano-Villanueva JL, Varón-Vega F, Estella Á, Loza-Vazquez A, Jorge-García R, Sancho I, Shankar-Hari M, Martin-Loeches I; LIVEN-Covid-19; SEMICYUC Study Group. Reyes LF, et al. Sci Rep. 2023 Apr 21;13(1):6553. doi: 10.1038/s41598-023-32265-5. Sci Rep. 2023. PMID: 37085552 Free PMC article.
Pharmacogenetics of adverse effects due to antiretroviral drugs.
Vidal F, Gutiérrez F, Gutiérrez M, Olona M, Sánchez V, Mateo G, Peraire J, Viladés C, Veloso S, López-Dupla M, Domingo P. Vidal F, et al. Among authors: olona m. AIDS Rev. 2010 Jan-Mar;12(1):15-30. AIDS Rev. 2010. PMID: 20216907 Review.
Validation of diagnostic tests.
Bermejo B, Masclans JR, Olona M, de Latorre FJ. Bermejo B, et al. Among authors: olona m. Intensive Care Med. 1993;19(5):304-5. doi: 10.1007/BF01690554. Intensive Care Med. 1993. PMID: 8408943 No abstract available.
Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomes.
Ceperuelo-Mallafré V, Reverté L, Peraire J, Madeira A, Maymó-Masip E, López-Dupla M, Gutierrez-Valencia A, Ruiz-Mateos E, Buzón MJ, Jorba R, Vendrell J, Auguet T, Olona M, Vidal F, Rull A, Fernández-Veledo S. Ceperuelo-Mallafré V, et al. Among authors: olona m. Front Immunol. 2022 Sep 14;13:912579. doi: 10.3389/fimmu.2022.912579. eCollection 2022. Front Immunol. 2022. PMID: 36189213 Free PMC article.
140 results